1 recruiting. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Recruiting 1 |
Follow CBX-663: new trials by email Literature Review of CBX-663 trials Research Report on CBX-663
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase 1, Open-Label, Dose-Escalation Study to Evaluate Safety, Tolerability, and Clinical Activity of CBX-663 in Participants With Relapsed or Refractory Myeloid Malignancies, Advanced Solid Tumors, or Recurrent or Progressive Glioblastoma. CBX-663 - Advanced Solid Tumors, Recurrent or Progressive Glioblastoma | Phase 1 | Recruiting | Crossbow Therapeutics, Inc. | 120 | 2026-08-04 | 2026-10-21 |
Recurrence (1)
Crossbow Therapeutics, Inc. (1)
United States (1)